NCT01083316
- Conditions
- Alzheimer Disease, Amyloidosis, Brain Diseases, +18 more
- Locations
-
- Boston Medical Center Boston, Massachusetts, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,003 public trials
2,033 recruiting studies
Immunoproliferative Disorders trial results
NCT00469209
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT00536978
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +20 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Completed
Efficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
NCT00290433
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT01570387
- Conditions
- AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
- Locations
-
- Boston Medical Center Boston, Massachusetts, United States
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
- Locations
-
- Site Reference ID/Investigator# 0241 La Jolla, California, United States
- Site Reference ID/Investigator# 0844 Fort Myers, Florida, United States
- Site Reference ID/Investigator# 0763 West Palm Beach, Florida, United States
- Site Reference ID/Investigator# 071 Louisville, Kentucky, United States
Completed
Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's Lymphoma
NCT00478959
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +6 more
- Locations
-
Not specified
NCT00075621
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +17 more
- Locations
-
- Cancer Research Center at Boston Medical Center Boston, Massachusetts, United States
Completed
Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination
NCT00442130
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT02178579
- Conditions
- Blood Protein Disorders, Cardiotoxicity, Cardiovascular Diseases, +21 more
- Locations
-
- University of Pennsylvania/Smilow Center for Translational Research Philadelphia, Pennsylvania, United States
- Vanderbilt University Medical Center Nashville, Tennessee, United States